IMMUNARRAY
Founded in 2006, ImmunArray is a molecular diagnostics company that developed a proprietary test to rule out the presence of the autoimmune disease lupus in blood samples. The test, which ImmunArray introduced last year, is significant because lupus is difficult to diagnose and can be mistaken for other autoimmune diseases. ImmunArray’s test helps avoid incorrect diagnosis and medication.
IMMUNARRAY
Social Links:
Industry:
Clinical Trials Health Care Health Diagnostics
Founded:
2006-01-01
Address:
Richmond, Virginia, United States
Country:
United States
Website Url:
http://www.immunarray.com
Total Employee:
51+
Status:
Active
Contact:
1(804)709-0144
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Font Awesome Apache Mobile Non Scaleable Content Google Apps For Business Unified Layer HostGator
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Molbio Diagnostics
Molbio Diagnostics is a molecular diagnostics manufacturer.
SUMORIT
SUMORIT is a Health Diagnostics company
Vitara Biomedical
Vitara Biomedical develops a therapeutic platform to support premature infants.
CareDx
CareDx is a novel molÂeÂcÂuÂlar diagnosÂtics comÂpany.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.immunarray.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "ImmunArray"
Immunarray
Welcome to ImmunArray. We use cookies to analyze website traffic and optimize your website experience.See details»
ImmunArray Company Profile 2024: Valuation, …
ImmunArray was founded in 2005. Where is ImmunArray headquartered? ImmunArray is headquartered in Rehovot, Israel. What is the size of ImmunArray? ImmunArray has 30 total employees. What industry is …See details»
ImmunArray - VentureRadar
ImmunArray is a molecular diagnostics company dedicated to the development of novel blood based test to support the diagnosis and management of complex acute and chronic immune …See details»
ImmunArray - Company Profile - Tracxn
Oct 23, 2024 ImmunArray develops microarray-based in vitro diagnostics for autoimmune diseases. Its proprietary platform is a custom single-use disposable microarray that is used to …See details»
Immunarray Pvt Company Profile | Management and Employees …
Immunarray Pvt Profile and History Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the …See details»
ImmunArray: Drug pipelines, Patents, Clinical trials - Synapse
Jun 14, 2023 Explore ImmunArray with its drug pipeline, therapeutic area, technology platform, 1 news. Explore ImmunArray with its drug pipeline, therapeutic area, technology platform, 1 …See details»
Immunarray Pvt. Ltd: Contact Details and Business Profile
Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support …See details»
ImmunArray - Israeli Startup | Startup Nation Finder
Dec 30, 2017 ImmunArray (IAL) is developing in-vitro diagnostic tests based on its iCHIP microarray technology platform. The products support a personalized medicine approach, and …See details»
Immunarray USA, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Immunarray USA, Inc. of Richmond, VA. Get the latest business insights from Dun & Bradstreet.See details»
ImmunArray - Org Chart, Teams, Culture & Jobs - The Org
View ImmunArray's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
ImmunArray Company Profile - Office Locations, Competitors
ImmunArray is a molecular diagnostics company dedicated to the development of blood-based tests to support the diagnosis and management of complex acute and chronic immune …See details»
Immunarray Pvt - Overview, News & Similar companies - ZoomInfo
Who is Immunarray Pvt. Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of nov el blood …See details»
ImmunArray - Contacts, Employees, Board Members, Advisors
ImmunArray has 3 current employee profiles, including Chairman & CEO Donna Edmonds. ImmunArray has 2 board members and advisors, including Robert C. Sledd . ContactsSee details»
Immunarray - StartupHub.ai
Immunarray. Save. Compare. 0. Score. AI Technology Score 10%. Funding Score 52%. Founders Score 48%. Business Overview. Inactive Status. 2006 Founded. $10M Funding. 1 # Rounds. …See details»
Quanterix And Immunarray Teaming Up To Address ... - BioSpace
Sep 28, 2016 About ImmunArray Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel …See details»
$10M Private Investment Funding for ImmunArray
Jul 13, 2016 ImmunArray, a molecular diagnostic company co-headquartered in Rehovot, Israel and Richmond, Virginia, whose novel blood tests are pioneering new and more accurate ways …See details»
Immunarray Ltd. - third500.com
Immunarray Ltd. Company Summary. ImmunArray Ltd is an early commercial stage diagnostics company with the ability to rapidly develop new diagnostic tests using its proprietary iCHIP® …See details»
Immunarray Ltd Announces The Licensing Of A Portfolio Of Novel …
Dec 3, 2024 ImmunArray therefore provides an important technology to the rapidly changing health care environment, and is a key company in our portfolio. It potentially enables a wide …See details»
Immunarray Spins Off Brainbox Solutions To Develop Traumatic …
In 2014, ImmunArray received a $300,000 grant from the GE NFL Head Health Challenge to further develop the JHU panel. The same year it launched the HeadSMART study, a …See details»